ATRN-119 in Combination With Decitabine in Patients With TP53-Mutated AML or Higher-Risk MDS

Clinical trial NCT07617363 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07617363
Sponsor: Washington University School of Medicine
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia High-risk Myelodysplastic Syndrome

Start date: 2026-08-31
Primary completion: 2030-01-31
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.